Hyperglycemia in extremely-low-birth-weight infants

Biology of the Neonate

Volumn 74, Issue 3, 1998, Pages 214-221

  Meetze, William ^a,b   Bowsher, Ronald ^a   Compton, Joyce ^a   Moorehead, Helen ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Extreme prematurity; Hyperglycemia; Insulin; Insulin like growth factors I and II

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN C;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERY LOW BIRTH WEIGHT;

EID: 0031846805     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014027     Document Type: Article

References (25)

1. Dweck HS, Cassady G: Glucose intolerance in infants of very low birth weight. Incidence of hyperglycemia in infants of birth weights 1,100 grams or less. Pediatrics 1974;53: 189-195.
2. Louik C, Mitchell AA, Epstein MF, Shapiro S: Risk factors for neonatal hyperglycemia associated with 10% dextrose infusion Am J Dis Child 1985;139:783-786.
3. Vaucher YE, Walson PD, Morrow G: Continuous insulin infusion in hyperglycemic, very low birth weight infants. J Pediatr Gastroenterol Nutr 1982;1:211-217.
4. Ostertag SG, Jovanovic L, Lewis B, Auld PAM: Insulin pump therapy in the very low birth weight infant. Pediatrics 1986;78:625-630.
5. Binder ND, Raschko PK, Benda GI, Reynolds JW: Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia. J Pediatr 1989;114:273-280.
6. Collins JW, Hoppe M, Brown K, et al: A controlled trial of insulin infusion and parenteral nutrition in extremely low birth weight infants with glucose intolerance. J Pediatr 1991;118:921-927.
7. Mauer AM, Dweck HS, Finberg L, Holmes F, Reynolds JW, Suskind RM, Woodruff CW: Nutritional needs of low-birth-weight infants. Pediatrics 1985;75:976-986.
8. Simeon PS, Gottesman MM: Neonatal continuous insulin infusion: A survey of ten level III nurseries in Los Angeles County. Neonat Netw 1991;9:19-25.
9. Pollak A, Cowett RM, Schwartz R, Oh W: Glucose disposal in low-birth-weight infants during steady-state hyperglycemia: Effects of exogenous insulin administration. Pediatrics 1978;61:546-549.
10. Lilien LD, Rosenfield RL, Baccaro MM, Pildes RS: Hyperglycemia in stressed small premature infants. J Pediatr 1979;94:454-459.
11. Goldman SL, Hirata T: Attenuated response to insulin in very low birth weight infants. Pediatr Res 1980;14: 50-53.
12. Cowett RM, Oh W, Schwartz R: Persistent glucose production during glucose infusion in the neonate. J Clin Invest 1983;71:467-475.
13. Cowett RM, Andersen GE, Maguire CA, Oh W: Ontogeny of glucose homeostasis in low birth weight infants. J Pediatr 1988;112:462-465.
14. Farrag HM, Nawraih LM, Healy JE, et al: Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. Am J Physiol 1997;272:E86-E93.
15. Usala A, Madigan T, Burguera B, Cefalu W, Sinha MK, Powell JG, Usala SJ: High dose intravenous, but not low dose subcutaneous, insulin-like growth factor-I therapy induces sustained insulin sensitivity in severely resistant type I diabetes mellitus. J Clin Endocrinol Metab 1994;79:435-440.
16. Cheetham TD, Jones J, Taylor AM, Holly J, Matthews DR, Dunger DB: The effects of recombinant insulinlike growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36: 678-681.
17. Schalch DS, Turman NJ, Marcsisin VS, Heffernan M, Hans-Peter G: Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus. J Clin Endocrinol Metab 1993;77:1563-1568.
18. Cusi K, DeFronzo RA: Treatment of NIDDM, IDDM, and other insulin-resistant states with IGF-I. Diabetes Rev 1995;3:206-236.
19. Wang HS, Lim J, English J, Irvine L, Chard T: The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-I in human umbilical cord serum at delivery: Relation to fetal weight. J Endocrinol 1991;129:459-464.
20. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche A: C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-I in umbilical cord serum: Correlations with birth weight. Am J Obstet Gynecol 1993;169:89-97.
21. Wathen NC, Wang HS, Cass PL, Campbell DJ, Chard T: Insulin-like growth factor-I and insulin-like growth factor binding protein-I in early human pregnancy. Early Hum Dev 1992;28:105-110.
22. Delmis J, Drazancic A, Ivanisevic M, Suchanek E: Glucose, insulin, HGH and IGF-I levels in maternal serum, amniotic fluid and umbilical venous serum: A comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation. J Perinat Med 1992;20:47-56.
23. Bowsher RR, Lee WH, Apathy JM, Obrien PJ, Ferguson AL, Henry DP: Measurement of insulin-like growth factor-II in physiologic fluids and tissues: An improved extraction procedure and radioimmunoassay for human and rat fluids. Endocrinology 1991;128:805-814.
24. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M: Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991;29:219-225.
25. Heird WC, Kashyap S: Intravenous feeding; in Hay WW (ed): Neonatal Nutrition and Metabolism. St Louis, Mosby Year Book, 1991, pp 237-259.